Teleflex Incorporated (TFX)
- Previous Close
206.71 - Open
206.84 - Bid 207.48 x 1200
- Ask 207.65 x 800
- Day's Range
206.45 - 208.56 - 52 Week Range
177.63 - 276.43 - Volume
107,764 - Avg. Volume
272,251 - Market Cap (intraday)
9.787B - Beta (5Y Monthly) 1.12
- PE Ratio (TTM)
27.45 - EPS (TTM)
7.57 - Earnings Date May 2, 2024
- Forward Dividend & Yield 1.36 (0.66%)
- Ex-Dividend Date Feb 29, 2024
- 1y Target Est
264.50
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
www.teleflex.com14,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: TFX
Performance Overview: TFX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TFX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TFX
Valuation Measures
Market Cap
9.74B
Enterprise Value
11.44B
Trailing P/E
27.34
Forward P/E
15.15
PEG Ratio (5yr expected)
2.39
Price/Sales (ttm)
3.29
Price/Book (mrq)
2.19
Enterprise Value/Revenue
3.85
Enterprise Value/EBITDA
15.03
Financial Highlights
Profitability and Income Statement
Profit Margin
11.98%
Return on Assets (ttm)
4.34%
Return on Equity (ttm)
8.45%
Revenue (ttm)
2.97B
Net Income Avi to Common (ttm)
357.57M
Diluted EPS (ttm)
7.57
Balance Sheet and Cash Flow
Total Cash (mrq)
239.73M
Total Debt/Equity (mrq)
44.54%
Levered Free Cash Flow (ttm)
373.86M
Research Analysis: TFX
Company Insights: TFX
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: TFX
TFX: Raising target price to $222.00
TELEFLEX INC has an Investment Rating of HOLD; a target price of $222.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetTFX: Lowering target price to $221.00
TELEFLEX INC has an Investment Rating of HOLD; a target price of $221.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetTFX: Raising target price to $235.00
TELEFLEX INC has an Investment Rating of HOLD; a target price of $235.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetTFX: Raising target price to $228.00
TELEFLEX INC has an Investment Rating of HOLD; a target price of $228.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target